EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:135939 - lacosamide
| Formula | C13H18N2O3 |
| Net Charge | 0 |
| Average Mass | 250.298 |
| Monoisotopic Mass | 250.13174 |
| SMILES | COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1 |
| InChI | InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1 |
| InChIKey | VPPJLAIAVCUEMN-GFCCVEGCSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Role: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. renoprotective agent Any compound that is able to prevent damage to the kidneys. anticonvulsant A drug used to prevent seizures or reduce their severity. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| lacosamide (CHEBI:135939) has role analgesic (CHEBI:35480) |
| lacosamide (CHEBI:135939) has role anticonvulsant (CHEBI:35623) |
| lacosamide (CHEBI:135939) has role antidepressant (CHEBI:35469) |
| lacosamide (CHEBI:135939) has role antineoplastic agent (CHEBI:35610) |
| lacosamide (CHEBI:135939) has role antipsychotic agent (CHEBI:35476) |
| lacosamide (CHEBI:135939) has role anxiolytic drug (CHEBI:35474) |
| lacosamide (CHEBI:135939) has role renoprotective agent (CHEBI:231911) |
| lacosamide (CHEBI:135939) is a N-acyl-amino acid (CHEBI:51569) |
| INN | Source |
|---|---|
| lacosamida | WHO MedNet |
| Synonyms | Source |
|---|---|
| ADD 243037 | ChEMBL |
| ADD-243037 | ChEMBL |
| ADD243037 | ChEMBL |
| erlosamide | DrugCentral |
| ertosamide | DrugCentral |
| harkoseride | DrugCentral |
| Brand Names | Source |
|---|---|
| Lacosamide accord | ChEMBL |
| Lacosamide adroiq | ChEMBL |
| Lacosamide ucb | ChEMBL |
| Motpoly xr | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| 4310 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| CAS:175481-36-4 | DrugCentral |
| Citations |
|---|